98 related articles for article (PubMed ID: 14674437)
1. Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice.
Aoyama T; Yamamoto S; Kanematsu A; Ogawa O; Tabata Y
Tissue Eng; 2003 Dec; 9(6):1289-99. PubMed ID: 14674437
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of matrix metalloproteinase-1 plasmid DNA prevents left ventricular remodeling in chronic myocardial infarction of rats.
Lin X; Jo H; Ishii TM; Fujita M; Fu M; Tambara K; Yamamoto M; Tabata Y; Komeda M; Matsuoka S
Circ J; 2009 Dec; 73(12):2315-21. PubMed ID: 19797822
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anti-fibrotic activity of plasmid DNA expressing small interference RNA for TGF-beta type II receptor for a mouse model of obstructive nephropathy by cationized gelatin prepared from different amine compounds.
Kushibiki T; Nagata-Nakajima N; Sugai M; Shimizu A; Tabata Y
J Control Release; 2006 Feb; 110(3):610-7. PubMed ID: 16378654
[TBL] [Abstract][Full Text] [Related]
4. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
5. Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds.
Kushibiki T; Tomoshige R; Iwanaga K; Kakemi M; Tabata Y
J Control Release; 2006 May; 112(2):249-56. PubMed ID: 16545479
[TBL] [Abstract][Full Text] [Related]
6. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
[TBL] [Abstract][Full Text] [Related]
7. Intramuscular injection of naked plasmid DNA encoding human preproinsulin gene in streptozotocin-diabetes mice results in a significant reduction of blood glucose level.
Wang LY; Sun W; Chen MZ; Wang X
Sheng Li Xue Bao; 2003 Dec; 55(6):641-7. PubMed ID: 14695479
[TBL] [Abstract][Full Text] [Related]
8. Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.
Kushibiki T; Matsumoto K; Nakamura T; Tabata Y
Pharm Res; 2004 Jul; 21(7):1109-18. PubMed ID: 15290849
[TBL] [Abstract][Full Text] [Related]
9. In vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres.
Kasper FK; Kushibiki T; Kimura Y; Mikos AG; Tabata Y
J Control Release; 2005 Oct; 107(3):547-61. PubMed ID: 16139915
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin.
Kushibiki T; Matsumoto K; Nakamura T; Tabata Y
Gene Ther; 2004 Aug; 11(15):1205-14. PubMed ID: 15103321
[TBL] [Abstract][Full Text] [Related]
11. Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis.
Kushibiki T; Nagata-Nakajima N; Sugai M; Shimizu A; Tabata Y
J Control Release; 2005 Jul; 105(3):318-31. PubMed ID: 15936840
[TBL] [Abstract][Full Text] [Related]
12. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
Liu M; Zhang Y; Chi Y; Zhai S; Wang B; Shi Y; Li Y
J Nephrol; 2012; 25(3):418-25. PubMed ID: 21928229
[TBL] [Abstract][Full Text] [Related]
13. Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice.
Takamiya Y; Fukami K; Yamagishi S; Kaida Y; Nakayama Y; Obara N; Iwatani R; Ando R; Koike K; Matsui T; Nishino Y; Ueda S; Cooper ME; Okuda S
Nephrol Dial Transplant; 2013 Jan; 28(1):55-62. PubMed ID: 23028104
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of stem cells obtained from murine dental pulp improves pancreatic damage, renal function, and painful diabetic neuropathy in diabetic type 1 mouse model.
Guimarães ET; Cruz Gda S; Almeida TF; Souza BS; Kaneto CM; Vasconcelos JF; Santos WL; Santos RR; Villarreal CF; Soares MB
Cell Transplant; 2013; 22(12):2345-54. PubMed ID: 23068779
[TBL] [Abstract][Full Text] [Related]
15. Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy.
Saito T; Tabata Y
Acta Biomater; 2012 Feb; 8(2):646-52. PubMed ID: 22079782
[TBL] [Abstract][Full Text] [Related]
16. The two isoforms of matrix metalloproteinase- 2 have distinct renal spatial and temporal distributions in murine models of types 1 and 2 diabetes mellitus.
Kim IY; Kim SS; Lee HW; Bae SS; Ha HK; Jung ES; Lee MY; Han M; Rhee H; Seong EY; Lee DW; Lee SB; Lovett DH; Song SH
BMC Nephrol; 2018 Sep; 19(1):248. PubMed ID: 30253743
[TBL] [Abstract][Full Text] [Related]
17. Renal expression of proto-oncogene Ets-1 on matrix remodeling in experimental diabetic nephropathy.
Liu DX; Liu XM; Su Y; Zhang XJ
Acta Histochem; 2011 Sep; 113(5):527-33. PubMed ID: 20598359
[TBL] [Abstract][Full Text] [Related]
18. Effects of pioglitazone on expressions of matrix metalloproteinases 2 and 9 in kidneys of diabetic rats.
Dong FQ; Li H; Cai WM; Tao J; Li Q; Ruan Y; Zheng FP; Zhang Z
Chin Med J (Engl); 2004 Jul; 117(7):1040-4. PubMed ID: 15265379
[TBL] [Abstract][Full Text] [Related]
19. Diltiazem attenuates oxidative stress in diabetic rats.
Anjaneyulu M; Chopra K
Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
[TBL] [Abstract][Full Text] [Related]
20. Klotho gene delivery ameliorates renal hypertrophy and fibrosis in streptozotocin-induced diabetic rats by suppressing the Rho-associated coiled-coil kinase signaling pathway.
Deng M; Luo Y; Li Y; Yang Q; Deng X; Wu P; Ma H
Mol Med Rep; 2015 Jul; 12(1):45-54. PubMed ID: 25695625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
